The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study. (2021)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(21)00212-5
PubMed Identifier: 34258590
Publication URI: http://europepmc.org/abstract/MED/34258590
Type: Journal Article/Review
Volume: 3
Parent Publication: The Lancet. Rheumatology
Issue: 9
ISSN: 2665-9913